4 Recruiting HER2-positive Breast Cancer Phase 1 Clinical Trials
Active phase 1 studies for her2-positive breast cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All HER2-positive Breast Cancer studiesPhase 1 Studies for HER2-positive Breast Cancer
🔵 Active, Not Recruiting Phase1 / Phase2
Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
📍 BRCR Medical Center Inc. — Plantation, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1
PRE-I-SPY Phase I/Ib Oncology Platform Program
📍 The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
📍 The University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔